European Study Is Good News For Sleep Apnea Devices
Patients with obstructive sleep apnea treated with positive airway therapy experienced significantly better outcomes than those not receiving the treatment, according to a new European study. After a series of setbacks, the study is positive news for sleep apnea device makers.
You may also be interested in...
The US FDA on 22 July designated a recent recall by Royal Philips of certain bi-level positive airway pressure (BiPAP), continuous positive airway pressure (CPAP), and other mechanical ventilator devices as high-risk class I.
The US FDA has designated a September recall by Teleflex of its Arrow-Trerotola Over-The-Wire PTD Kit Percutaneous Thrombolytic Device: 7FR as high-risk class I.
Blackrock Neurotech’s MoveAgain technology platform allows patients who have been silenced by ALS, paralysis and other spinal cord injuries the ability to better communicate via text. The device has been granted breakthrough status by the US FDA.